OpenAI offers US university labs up to 30 free research seats for one year

What the free plan includes

OpenAI has introduced the Rosalind Academic Plan for university research laboratories in the United States. Approved labs can receive up to 30 ChatGPT Business Standard seats at no charge for as long as 12 months, according to OpenAI’s announcement. The offer is for research teams rather than individual students, and it does not include API access.

Business Standard provides access to commercially available frontier models within the plan’s usage limits. GPT‑Rosalind, OpenAI’s specialist model for life-science research, is not automatically included: a laboratory must also pass the company’s trusted-access review. OpenAI says data submitted through the academic plan is not used to train its models by default.

A laboratory without an existing institutional Enterprise agreement can apply through its research leader. If the university already has such an agreement, the team is directed to use that access instead. Once approved, the lead researcher can name up to 30 members and is responsible for permissions and appropriate use. OpenAI has not said how many labs it expects to accept, how quickly applications will be decided or what pricing might apply after the free period.

Why access is screened

The plan is connected to GPT‑Rosalind and Rosalind Workbench, a set of research tools intended for tasks in drug and protein design, medicinal chemistry, genomics and laboratory experimentation. These capabilities can accelerate legitimate scientific work, but some biological or chemical applications can also carry heightened risks.

OpenAI therefore says it checks the institution, the lead researcher’s identity and appointment, affiliation, research area, intended use and willingness to act as a safety contact. Monitoring continues after activation, and sensitive cases can trigger contextual checks or follow-up with the researcher. This makes the program a controlled access channel rather than a general academic giveaway.

The original report by The Decoder accurately highlights the two practical boundaries most applicants need to know: participation is currently limited to US university labs, and the free seats cover ChatGPT rather than programmatic API use.

Tools are meant to support, not replace, laboratory judgment

OpenAI presents examples in which researchers use the system to search scientific sources, organize evidence or explore candidate molecules. In one cited collaboration, a UCSF lab used it to work with physicochemical property information from PubChem and NCBI while distinguishing estimated values from measured ones. That distinction is important: a model can help locate, compare and reason over research data, but its output is not itself experimental validation.

For qualifying labs, the immediate value is reduced cost for shared AI tools and a path to specialist capabilities. The constraints are equally clear: access is selective, usage limits still apply, GPT‑Rosalind needs additional approval, and findings must still be checked against primary data and laboratory evidence.